A regulated cannabis market can genuinely and sustainably displace the black market—new comprehensive data from Swiss pilot projects, presented by the Swiss Federal Office of Public Health (BAG) in early March 2026, now proves this conclusively.
📑 Inhaltsverzeichnis
The extensive analysis covers the period from mid-2024 to mid-2025 and draws on detailed information from over 10,000 registered participants across various cantons. The central finding is unmistakable: high product quality and guaranteed safety far outweigh illegal pricing and old purchasing habits.
Legal Sources Become the Undisputed First Choice
The most significant and politically important result of this large-scale analysis appears in consumption patterns: for the absolute majority of study participants, the legal dispensing points of the pilot projects quickly became their primary and often only source. The illegal market loses massive significance in these regions—remarkably, not because of stricter police enforcement, but simply because the legal offering structurally convinces consumers. Participants particularly appreciate guaranteed, lab-tested product quality, access to professional and anonymous consultation, and the complete elimination of acquisition-related crime and shady transactions.
This is an enormously relevant message with major implications for heated debate elsewhere. While law enforcement officials in other countries point out that black markets continue to flourish despite new cannabis legislation, Switzerland provides a plausible explanation for this phenomenon. Many countries lack a genuine, nationwide legal supply structure for the general population. In Switzerland, by contrast, pilot study participants can shop at certified pharmacies or specially controlled dispensing points—with intensive consultation, clearly defined quality standards, and full transparency about all ingredients. Earlier, smaller analyses had already hinted at how effective this Swiss approach systematically dries up the black market.
Health and Consumption Safety Measurably Improved
Beyond the measurable effect on the black market, the current BAG report documents significant health improvements among participants. Many reported substantially increased overall wellbeing in surveys. Researchers attribute this effect partly to the complete elimination of chronic acquisition stress and a noticeable reduction in social stigma in daily life. When people no longer need to buy products covertly or in criminal environments, they consume more relaxed and thoughtfully.
Particularly striking for public health officials: professional consultation at dispensing points demonstrably led many participants to actively change their consumption methods. Gentler approaches like vaporizers are used significantly more frequently, while the traditional, more harmful joint is smoked less often. This is strong empirical evidence that factual information and education actually work when delivered at the point of sale. This is a powerful argument for legalization advocates, because a regulated market enables targeted prevention work that is simply impossible in illegal and uncontrolled settings.
What Switzerland Does Structurally Better
The Swiss pilot projects are structurally unique in Europe. They operate under strict scientific oversight, are limited to clearly defined participant groups, and are continuously evaluated by federal authorities. The renowned Züri Can project in Zurich, operating through ten selected pharmacies as official dispensing points, and the Cannabis Research Zurich initiative with over 4,400 participants alone provide particularly robust and detailed data.
What fundamentally distinguishes Switzerland is the existence of a functioning, professional dispensing structure. This is neither logistically nor politically trivial. While cannabis social clubs in other countries may supply members, the legal hurdles are enormous. Membership is capped at exactly 500 people, bureaucratic approval procedures sometimes take up to two years, and nationwide only around 293 licenses have been issued—with thousands of applications still pending and blocked. The dramatic regional disparities and political arbitrariness in licensing for these organizations are starkly evident when comparing individual regions.
A Model for the Next Stage of Legalization?
The Swiss data certainly don’t provide a one-to-one copyable model—the legal, political, and social frameworks of different countries are too distinct. But they provide an unbeatable, evidence-based argument for future drug policy direction: when product quality and accessibility for adults are right, people voluntarily and permanently choose the legal market. The underlying principle is the same one explaining how a thoughtfully regulated system can not merely combat the black market superficially, but structurally and economically eliminate it.
For other countries, this means finally taking the long-announced next step—establishing licensed retail sales, building functioning commercial distribution structures, and creating significantly more access points. Current health policy discussions focus almost exclusively on bureaucratic barriers and restrictions in existing laws. However, pilot data from neighboring countries remind us that the truly interesting question hasn’t yet been seriously addressed: what would a genuinely functioning, comprehensively regulated market look like—one that doesn’t merely limit illegal trade, but permanently and effectively displaces it?
Frequently Asked Questions About Swiss Pilot Projects
What did the 2025 evaluations show?
The detailed analysis of pilot trials from mid-2024 to mid-2025, involving over 10,000 people, paints a clear picture. For the vast majority of consumers, certified legal sources have become the primary option in daily life. Users rate guaranteed ingredient safety and professional consultation offerings significantly higher than the alleged price advantage of the illegal market. This succeeds entirely without additional police enforcement measures.
Why does the Swiss model work better than other cannabis legislation?
The decisive difference lies in infrastructure. Switzerland has professionally operated, certified dispensing points in established pharmacies and special distribution centers that ensure low-barrier access. Other countries currently only allow volunteer-run cultivation associations and private home growing. Both pillars fall far short logistically of meeting the population’s enormous overall demand. Consumers who can’t find a place in limited associations have essentially no legal alternative to street dealing.
What is Züri Can?
Züri Can is a large-scale, scientifically rigorous pilot project launched by the City of Zurich in cooperation with the University of Zurich. Since summer 2023, registered participants have been able to purchase under regulated conditions at ten certified city pharmacies and the Drug Information Center (DIZ). This long-term study’s overarching goal is precise evaluation of such a market’s impact on individual consumption behavior, public health, and illegal trade structures.
What would need to change to achieve similar success elsewhere?
To effectively push back illegal trade, other countries would need a nationwide system of licensed retail outlets for adults. This would resemble models in Canada, some U.S. states, or Swiss pilot projects. As long as a large portion of consumers find no convenient legal purchasing option, the unregulated market remains economically attractive. Data from neighboring countries impressively demonstrate that a functioning, customer-friendly dispensing system works far more effectively than pure law enforcement.
How many people participate in Swiss studies?
Over 10,000 people now participate in various cantonal pilot projects. The most recent and comprehensive analysis of this user data was published by the Federal Office of Public Health in March 2026. The renowned Cannabis Research Zurich project alone counted over 4,400 active participants in its latest phase. The parallel Züri Can project, integrated into city pharmacy infrastructure, runs as scheduled until October 2026 and continues providing additional data.
Sources and Further Reading:
- Federal Office of Public Health BAG: Publication of evaluation reports on pilot trials (as of March 2026) – Official announcement
- City of Zurich: Information and interim results from the Züri Can research project – Züri Can project website
- University of Zurich: Accompanying research and data analysis for Cannabis Research Zurich – UZH research reports
Branchen-Update
News, Analysen und Reportagen — mehrmals im Monat direkt in dein Postfach.
Folge uns
